FDA Archives - Page 21 of 25

Podcast: KHN’s ‘What The Health?’ Reading The Tea Leaves In Blue Wave’s Wake

In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times, Alice Ollstein of Politico and Anna Edney of Bloomberg News discuss the impact of House Democratic leadership elections and their impact on health policy; as well as efforts by the Trump administration to address high drug prices and ensure the safety of medical devices. Plus, Julie Rovner interviews KHN’s Jay Hancock about the latest “Bill of the Month.”

Nov. 29, 2018

Podcast: KHN’s ‘What The Health?’ Health Nerd Books For The Holidays

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Joanne Kenen of Politico and Anna Edney of Bloomberg News discuss the latest on open enrollment for the Affordable Care Act and Medicare; new moves by the Food and Drug Administration to regulate tobacco and nicotine products; and whether House Democrats will pursue a “Medicare-for-all” bill in the next Congress. Plus, for extra credit, the panelists recommend their favorite health policy books for your holiday reading and gifting pleasure.

Nov. 20, 2018

Fish Oil Drug Looks Heart-Healthy. Just Don’t Swallow It Hook, Line And Sinker.

The complete findings of a recent study show the FDA-approved drug Vascepa reduced the likelihood of cardiovascular death, stroke and other heart conditions in some patients. But science didn’t find the same promise for over-the-counter fish oil supplements when tested in healthy people.

By Shefali Luthra

Nov. 20, 2018

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Nov. 16, 2018

Heart Drug Spotlights Troubling Trends In Drug Marketing

Critics worry the marketing of Vascepa, a purified fish oil product, could prove a fish story.

By Shefali Luthra

Nov. 2, 2018

Hidden Drugs And Danger Lurk In Over-The-Counter Supplements, Study Finds

Dieters and gym rats, beware. Some dietary supplements promising weight loss or more muscle may contain active ingredients not listed on the label that fly under the radar of the Food and Drug Administration. The California Department of Public Health analyzed public data maintained by the FDA to suss out trends among tainted products, raising red flags.

By Rachel Bluth

Oct. 12, 2018

Podcast: KHN’s ‘What The Health?’ Falling Premiums And Rising Political Tensions

In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Rebecca Adams of CQ Roll Call, Anna Edney of Bloomberg News and Julie Appleby of Kaiser Health News discuss the Trump administration’s announcement that average premium prices are falling on the Obamacare marketplaces, the effort by Senate Democrats to reverse rules on short-term health insurance and the focus on protections for people with preexisting conditions in the run-up to midterm elections.

Oct. 11, 2018

The Feds’ Termination Of A Tiny Contract Inflames Bitter Fight Over Fetal Tissue

Just weeks before midterm elections, a move by federal health officials spotlights a contentious issue: the use of human fetal tissue in research. Here’s what you need to know to understand the debate.

By Emmarie Huetteman

Oct. 8, 2018

Podcast: KHN’s ‘What The Health?’ Some Things Old, Some Things New

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner discuss final action on bills in Congress to address the opioid epidemic and fund federal health agencies. They also look at new efforts by the Food and Drug Administration to crack down on teen nicotine use.

Oct. 4, 2018

Drugmakers Play The Patent Game To Lock In Prices, Block Competitors

Pharmaceutical companies like Purdue Pharma, maker of OxyContin, often win patents for incremental changes with debatable value. Now there’s a twist involving an opioid treatment.

By Sarah Jane Tribble

Oct. 2, 2018

Buried In Congress’ Opioid Bill Is Protection For Personal Drug Imports

The protection is a win for people who get their needed, legitimate drugs from overseas.

By Michael McAuliff

Sept. 27, 2018

As States Try To Rein In Drug Spending, Feds Slap Down One Bold Medicaid Move

Medicaid drug spending doubled in five years in Massachusetts. The state wanted to exclude expensive drugs that weren't proven to work better than existing alternatives from its Medicaid plan, but the federal government blocked the effort.

By Martha Bebinger, WBUR

Sept. 21, 2018

Half As Many People Are Trying Heroin, But Marijuana Use Grows

An annual government survey of drug use and health shows a dramatic drop in the number of people who tried heroin but an uptick in pot use.

By Jenny Gold

Sept. 14, 2018

Podcast: KHN’s ‘What The Health?’ A Detour On A Smoking Off-Ramp

In this episode of KHN’s “What the Health?” Sarah Jane Tribble of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Kimberly Leonard of the Washington Examiner and Rebecca Adams of CQ Roll Call talk about the Food and Drug Administration’s latest actions to address teenagers’ use of e-cigarettes, Arkansas’ Medicaid work requirements and news about the uninsured from the latest federal Census report.

Sept. 13, 2018

Cancer, Schmancer. In California, Coffee Is King

The Golden State, with the rare support of the Trump administration, is seeking to circumvent a court order that would require cancer warnings in every establishment that sells a hot cup of Joe.

By Ana B. Ibarra

Aug. 31, 2018

Podcast: KHN’s ‘What The Health?’ Opioids, EpiPens And Health Funding

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico discuss Senate action on health funding and opioid legislation, the state of the individual insurance market and consternation over expiration dates on EpiPens, the self-injected allergy remedy. Also, could an otter with asthma signal a potential public health crisis?

Aug. 23, 2018

Insuring Your Health

Biorhythms And Birth Control: FDA Stirs Debate By Approving ‘Natural’ App

Critics worry about the message federal officials are sending by approving a new birth control option, which uses a mobile phone app for women to track their body temperature and menstrual cycle to avoid pregnancy. But the more choices the better, some reproductive health experts say.

By Michelle Andrews

Aug. 21, 2018

Trump Administration Sinks Teeth Into Paring Down Drug Prices, On 5 Key Points

Instead of waiting for congressional action, federal regulators are looking at a series of actions to spur competition and drive down the cost of medicines.

By Sarah Jane Tribble

Aug. 10, 2018

Pharmacy-Made Pain Creams Flagged On Fears Of Medicare Fraud And Risk

Inspector general identifies possible problems in nearly 23 percent of pharmacies that bill Medicare for blended creams, gels and lotions.

By Julie Appleby

Aug. 9, 2018

Podcast: KHN’s ‘What The Health?’ Congress And Health Care. Again.

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Alice Ollstein of Talking Points Memo and Kimberly Leonard of the Washington Examiner talk about the new push on health legislation by Republicans in the House, as well as developments on Medicaid work requirements, drug prices and the fate of children separated from their parents at the U.S.-Mexican border. Plus, for extra credit, the panelists offer their favorite health stories of the week.

July 26, 2018

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics

FDA